Evidence map›Paper›PMID 8691135›Full record

ArticleThe Journal of experimental medicine1996

The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.

G H Su, H S Ip, B S Cobb, M M Lu, H M Chen, M C Simon

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of experimental medicine, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Article
  3. M cell-dependent commensal uptake confers encephalitogenic phenotypes on γδT17 cells in Peyer's patches.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Frontiers in pharmacology · 2025
    Article
  6. Effective Pruning for Top-k Feature Search on the Basis of SHAP Values.IEEE access : practical innovations, open solutions · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Expression and Clinical Significance of Spi-B in B-cell Acute Lymphoblastic Leukemia.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

G H SuDepartment of Medicine, University of Chicago, Illinois 60637, USA.
H S Ip
B S Cobb
M M Lu
H M Chen
M C Simon
University of Chicago · US

Funding

SPI-1 AND SPI-B AND HEMATOPOIETIC DEVELOPMENTR01HL052094 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SIMON, M. CELESTE · 1994 to 2002
$542k
NHLBI NIH HHS HL52094-02
6 · The paper itself

Abstract

Spi-B and PU.1 are hematopoietic-specific transcription factors that constitute a subfamily of the Ets family of DNA-binding proteins. Here we show that contrary to previous reports, PU.1 and Spi-B have very different expression patterns. PU.1 is expressed at high levels in B cells, mast cells, megakaryocytes, macrophages, neutrophils, and immature erythroid cells and at lower levels in mature erythrocytes. PU.1 is completely absent from peripheral T cells and most T cell lines based on sensitive RT-PCR assays. In contrast, Spi-B is expressed exclusively in lymphoid cells and can be detected in early fetal thymus and spleen. In situ hybridizations of adult murine tissues demonstrate Spi-B mRNA in the medulla of the thymus, the white pulp of the spleen, and the germinal centers of lymph nodes. Spi-B expression is very abundant in B cells and both Spi-B mRNA and protein are detected in some T cells. In situ hybridization and Northern blot analysis suggest that Spi-B gene expression increases during B cell maturation and decreases during T cell maturation. Gel-retardation experiments show that Spi-B can bind to all putative PU.1 binding sites, but do not reveal any preferred Spi-B binding site. Finally, both PU.1 and Spi-B function as transcriptional activators of the immunoglobulin light-chain enhancer E lambda 2.4 when coexpressed with Pip (PU.1-interaction partner) in NIH-3T3 cells. Taken together, these data suggest that differences in patterns of expression between Spi-B and PU.1 distinguish the function of each protein during development of the immune system.

Indexed as

Trans-ActivatorsBase SequenceBlotting, WesternB-LymphocytesCell LineDNA-Binding ProteinsDNA PrimersEnhancer Elements, GeneticGene Expression Regulation, DevelopmentalHematopoiesisHumansImmunoglobulin kappa-ChainsIn Situ HybridizationMolecular Sequence DataProto-Oncogene ProteinsProto-Oncogene Protein Spi-1DNA-Binding ProteinsDNA PrimersImmunoglobulin kappa-ChainsProto-Oncogene ProteinsProto-Oncogene Protein Spi-1RNA, MessengerSPIB protein, humanTrans-ActivatorsTranscription Factors

Identifiers

PMID8691135
PMCPMC2192671
OpenAlexW2005735929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.